WearOptimo’s Advisory Board members are:

• Dr. Robert Langer – Massachusetts Institute of Technology (MIT) has cofounded 40+ businesses, including Moderna, Momenta, and Living Proof, and was on the founding scientific advisory board of Alnylam. Dr Langer has more than 1,500 patents issued and pending, licensed or sublicensed to more than 400 companies. He is the most cited engineer in history and has received more than 220 awards, including the Queen Elizabeth prize for engineering (considered the engineering Nobel prize), Kavli Prize, Wolf Prize and is one of only three people to receive both the U.S. National medal of science and the U.S. National Medal of Technology and Innovation.
  
  
• Dr. Douglas E. Williams, Ph.D. – Former EVP of R&D at Biogen and a leading figure in biopharmaceutical innovation, business building and effectively taking health products to market. During his 30+ year career, Dr. Williams has held leadership positions in the biotechnology industry, including EVP of R&D at Biogen, and CEO roles at Codiak BioSciences and ZymoGenetics (where he led a $985 M trade sale to Bristol Meyers Squibb). He has played a role in the development of several novel drugs now on the market, including Leukine, Enbrel, Adcetris, Tecfidera, Alprolix, Eloctate, and Spinraza. He has served on the Board of Directors and Advisory Boards of more than two dozen biotechnology companies.
  
  
• Peter Barton Hutt – Renowned FDA regulatory expert and former Chief Counsel for the U.S. FDA. A Leading expert in Food and Drug Law, he has shaped the field throughout his career. Peter served as Chief Counsel for the U.S. Food and Drug Administration (FDA), as an advisor to academic, philanthropic, and venture capital boards, and serves on health/biotech company boards, including Moderna, and advisory boards. He was the lead co-author of the definitive casebook on Food and Drug Law that is widely used in the U.S. Peter is a professor at Harvard Law School, where he has taught Food and Drug Law since 1994.
  
  
• Dr. Luke Bennett – Former Director of Hintsa Performance, where he led medical and driver performance programs over nine dominant seasons in Formula One. Dr. Bennett is a world-leading expert in athletic health and performance and now CEO and Co-Founder of 10 SQUARED with Dr. Peter Attia. He brings unparalleled insights into the physiological demands of cutting-edge sports, data-driven performance optimization, and the importance of real-time health monitoring. Dr. Bennett will advise on the application of WearOptimo’s hydration sensors in elite sports, supporting adoption by professional teams, leagues, and athletes across global high-performance environments.
  
  
• Jeff Wong – Former Global Chief Innovation Officer at EY. At EY, his role was to take his experience of working in Silicon Valley to challenge everything, from the way EY did business internally, to the way it engaged with clients and strategic alliance partners. Additionally, he led EY’s advanced technology efforts in AI, Blockchain, and Quantum computing. Jeff brings deep experience across strategy, investing, and building new ventures globally. Throughout his career, he has built new businesses across a variety of concepts, including local commerce, B2B exchanges, services, mobile, and big data. Jeff serves as a senior advisor to several companies and is an Adjunct Lecturer in the School of Engineering at Stanford University.
  
  
• Dr. Peter Wrighton-Smith, Ph.D. – Founder and former CEO of Oxford Immunotec, a global immunology focussed in-vitro diagnostics company, which he led from spin-out to Nasdaq IPO to acquisition. During that time, 2002-2022, he grew the company from one to 500 employees with $100 M in revenue and sales to more than 50 countries through direct sales teams across the U.S., Europe, China, and Japan. He serves as a Director on several life sciences and technology companies and is Chairman of IonOpticks. At the University of Oxford, he earned his Masters of Engineering, Economics and Management, and then his DPhil (PhD) in Medical Engineering.

The company’s vision and innovative IP portfolio have already secured commercial traction with Aspen Medical (serving mining and defense markets) and elite sports partnerships, including investment from Formula 1 champion Mark Webber. The addition of this world-class Advisory Board further strengthens WearOptimo’s position as a global leader in wearable health technology.